NEW YORK (GenomeWeb) – The exotic CRISPR enzyme C2c2 has two different RNA cleaving functions — one for cutting its target and another for processing its guiding CRISPR RNA. The distinct RNase activities of the RNA-guided, RNA-targeting C2c2 enzyme were parsed in a new Nature study led by University of California, Berkeley scientists Jennifer Doudna and Robert Tijan.

http://www.nature.com/nature/journal/vaop/ncurrent/full/nature19802.html

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.